Ixcela research comes from in-house experimentation (conducted with pharmaceutical partners like Pfizer, nonprofit organizations like NASA, and academic institutions such as Harvard, Massachusetts General Hospital, Duke, and Mayo Clinic), peer-reviewed literature, and clinical studies conducted at other laboratories around the world.